3,854
Participants
Start Date
December 30, 2020
Primary Completion Date
May 15, 2021
Study Completion Date
October 29, 2021
MVC-COV1901(S protein with adjuvant)
Approximately 3180 participants will receive 2 doses of MVC-COV1901(S-2P protein with adjuvant) at Visit 2 (Day 1) and Visit 4 (Day 29) via intramuscular (IM) injection in the deltoid region
MVC-COV1901(Saline)
Approximately 530 participants will receive 2 doses of MVC-COV1901(Saline) at Visit 2 (Day 1) and Visit 4 (Day 29) via IM injection in the deltoid region
Changhua Christian Hospital, Changhua
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
China Medical University Hospital, Taichung
National Cheng Kung University Hospital, Tainan City
National Taiwan University Hospital, Taipei
Taipei Medical University Hospital, Taipei
Taipei Municipal Wan Fang Hospital, Taipei
Taipei Veteran General Hospital, Taipei
Tri-Service General Hospital, Taipei
Chang-Guang Memorial Hospital Lin-Kou, Taoyuan District
Tao-Yuan General Hospital, Taoyuan District
National Institute of Hygiene and Epidemiology, Hanoi
Lead Sponsor
Medigen Vaccine Biologics Corp.
INDUSTRY